Genocea is harnessing the power of T cell immunity to develop life-changing vaccines and immunotherapies. While traditional immunotherapy discovery methods have largely used predictive methods to propose T cell targets, or antigens, Genocea has successfully developed ATLAS™, its proprietary technology platform, to identify clinically relevant antigens of T cells based on actual human immune responses. Genocea is currently using ATLAS in immuno-oncology applications to develop neoantigen cancer vaccines, general cancer vaccines and a vaccine targeting cancers caused by Epstein-Barr Virus.
Looking for a particular Genocea employee's phone or email?
Genocea Questions
The Genocea annual revenue was $11 million in 2026.
Patricia Manning is the Vice President, Human Resources of Genocea.
3 people are employed at Genocea.
Genocea is based in Cambridge, Massachusetts.
The NAICS codes for Genocea are [325, 32, 325414, 32541, 3254].
The SIC codes for Genocea are [28, 283].
Top Genocea Employees
-
Patricia Manning
Vice President, Human Resources at Genocea
Massachusetts, United States45+ -
Craig Carey
Senior Director, Program Lead at Genocea
Windham, New Hampshire, United States22 -
Tuan Pham
IT Infrastructure Manager at Genocea
Boston, Massachusetts, United States3
Related Companies
